ICD-10-CM Billable Code

C05.1

Malignant neoplasm of soft palate

Clinical Classification Guidelines

Excludes Type 2

  • malignant neoplasm of nasopharyngeal surface of soft palate (C11.3)

Medical Intelligence & Overview

Malignant neoplasm of the soft palate, classified under ICD-10 code C05.1, refers to a cancerous tumor that develops in the soft palate, a soft tissue element forming the back of the roof of the mouth. This type of cancer is part of head and neck cancers and requires specialized diagnosis and treatment. The soft palate separates the nasal cavity from the oral cavity and plays a role in speech and swallowing. When affected by malignancy, it can significantly impact quality of life due to its location and functions.

Causes & Symptoms

Clinical Causes: Tobacco use, including smoking cigarettes, cigars, or pipe tobacco Heavy alcohol consumption Human papillomavirus (HPV) infection, particularly high-risk strains Prolonged exposure to certain chemicals or inhalants Poor oral hygiene and chronic mouth irritation History of other head and neck cancers Genetic predisposition and family history Gender (males are at higher risk than females) Age (most cases occur in older adults)

Key Symptoms: Persistent sore throat or a feeling of something stuck in the throat Pain or numbness in the soft palate or around the ear Difficulty swallowing (dysphagia) Unexplained weight loss Lumps or swelling in the neck due to lymph node involvement Changes in voice or speech difficulties Bleeding or ulceration in the mouth Unusual nasal congestion or stuffiness Ear pain or hearing loss

Diagnostic & Treatment

Diagnosis Path: Diagnosis of malignant neoplasm of the soft palate involves a combination of clinical evaluation and diagnostic tests. Initially, a healthcare provider conducts a physical examination of the mouth, throat, and neck to check for irregularities, lumps, or ulcers. Further assessment may include: - **Imaging studies**: Such as MRI, CT scans, or PET scans to determine the tumor's size, location, and spread. - **Biopsy**: Obtaining tissue samples from the lesion for histopathological examination to confirm malignancy. - **Endoscopy**: Using a flexible scope to visualize the soft palate and adjacent areas. Additional tests, including blood work, may be performed to evaluate overall health and readiness for treatment.

Treatment Protocols: Treatment options depend on the stage and extent of the tumor and often involve a multidisciplinary approach. Common modalities include: - **Surgery**: Removal of the tumor, which may involve partial removal of the soft palate and neighboring tissues. In some cases, reconstructive surgery is necessary. - **Radiation therapy**: Using high-energy radiation to kill cancer cells or shrink tumors. - **Chemotherapy**: Medications that destroy cancer cells, sometimes used in conjunction with radiation, especially in advanced cases. - **Targeted therapy and immunotherapy**: Emerging treatments targeting specific cancer cell characteristics or boosting the immune response. Follow-up care includes monitoring for recurrence, managing side effects, and rehabilitative services such as speech therapy if needed.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C05.1 a billable ICD-10 code?
Yes, C05.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C05.1?
Clinical documentation must specify the nature of Malignant neoplasm of soft palate and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

neoplasm palate malignant